NIKKI LOVE: Open Payments
NPI 1962797274 · SACRAMENTO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,791 in 38 payments from 13 companies in 2025. Trend: 2023 $171 · 2024 $592 · 2025 $1,791
Travel & lodging: $966Food & beverage: $808Education: $16
| Company | Payments | Amount |
|---|---|---|
| Vantive US Healthcare LLC | 12 | $1,264 |
| Novartis Pharmaceuticals Corporation | 3 | $87 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $69 |
| Novo Nordisk Inc | 4 | $67 |
| Ardelyx, Inc. | 3 | $59 |
| Travere Therapeutics, Inc. | 3 | $49 |
| Mallinckrodt Hospital Products Inc. | 2 | $40 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $38 |
| Otsuka America Pharmaceutical, Inc. | 1 | $32 |
| GlaxoSmithKline, LLC. | 1 | $30 |
Products named: Renal - Chronic, Fabhalta, Renal - PD, Kerendia, Ozempic, IBSRELA, ACTHAR, JARDIANCE.
Industry payments across CA — which companies pay providers there.
